Product Information

NESTABS DHA COMBO PACK is a brand product labeled by WOMENS CHOICE PHARMACEUTICALS LLC, priced at $3.1873 per EA under NDC 50967031730. Its NADAC has been published 334 times since Nov 28, 2013.

Price Statistics

The NADAC for NESTABS DHA COMBO PACK has been published 334 times since Nov 28, 2013, and over the history we have for it it has risen 246.1%. The table below summarizes its recorded NADAC range and movement.

Current price$3.1873 per EA
All-time high$3.1873 (Jul 16, 2025)
All-time low$0.9209 (Nov 28, 2013)
52-week high$3.1873
52-week low$3.1873
Median price$1.7249
Average price$1.9264
Largest weekly change+42.1% (Jun 19, 2024)
Weeks tracked334
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+42.1%

5Y

+42.1%

All

+246.1%

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of NESTABS DHA COMBO PACK?

The current National Average Drug Acquisition Cost (NADAC) for NESTABS DHA COMBO PACK, manufactured by WOMENS CHOICE PHARMACEUTICALS LLC, is $3.1873 per EA (NDC 50967031730), effective Jul 16, 2025.

How has the price of NESTABS DHA COMBO PACK changed over time?

Over the history we have for it, the NADAC for NESTABS DHA COMBO PACK has risen 246.1%. It has been tracked across 334 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for NESTABS DHA COMBO PACK?

Since Nov 28, 2013, the NADAC for NESTABS DHA COMBO PACK has ranged from a low of $0.9209 (Nov 28, 2013) to a high of $3.1873 (Jul 16, 2025), with a median of $1.7249 per EA.

Are there cheaper alternatives to NESTABS DHA COMBO PACK?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of NESTABS DHA COMBO PACK, so no direct lower-cost alternative is listed.

Who manufactures NESTABS DHA COMBO PACK?

NESTABS DHA COMBO PACK (NDC 50967031730) is labeled by WOMENS CHOICE PHARMACEUTICALS LLC, and CMS classifies it as a brand product.

Related Drugs

Same classification

No related drugs found.